Cisplatin is a platinum-containing chemotherapy drug used for several cancers. Here’s a concise overview to help you understand it.
What cisplatin is and how it works
- It’s given as an IV infusion.
- It forms crosslinks in DNA, which interferes with cell replication and triggers cancer cell death.
- It is a powerful but often very toxic chemotherapy agent, so it’s used in specific regimens and monitored closely.
Common cancers and regimens (examples)
- Testicular cancer: often part of BEP (bleomycin, etoposide, cisplatin) regimens.
- Ovarian and cervical cancers: can be used in combination regimens.
- Head and neck cancers, bladder cancer, certain lung and esophageal cancers: cisplatin-containing regimens are common.
- Because dosing and schedule vary by cancer type and specific protocol, your oncologist will choose the regimen and dose.
How it’s given and key supportive care
- Administration: IV infusion, usually in cycles (e.g., every 3 weeks or weekly, depending on the regimen).
- Hydration is essential: patients typically receive IV fluids before and after cisplatin to protect kidney function. Sometimes diuretics are used during administration.
- Antiemetics: strong nausea and vomiting are common, so preventive antiemetics are standard.
- Monitoring during treatment: kidney function (creatinine, BUN), electrolytes (magnesium, potassium, calcium), blood counts, liver enzymes; hearing tests may be done, especially if you’ll get multiple cycles.
- Hydration and electrolyte management: low magnesium, potassium, and calcium are common; these may need to be replaced during treatment.
Common side effects and how they’re managed
- Kidney (nephrotoxicity): risk minimized with hydration and avoiding other kidney toxins.
- Ear/hearing (ototoxicity): can cause hearing loss or ringing in the ears; especially in higher cumulative doses.
- Nerve problems (neurotoxicity): numbness/tingling in hands/feet; can be dose-dependent.
- Electrolyte abnormalities: low magnesium, potassium, calcium; may require supplements.
- Nausea/vomiting: well-managed with antiemetics.
- Low blood counts (less common with cisplatin than with some other chemo drugs, but can occur): risk of infections, fatigue.
- Hair loss is less common with cisplatin than with some other regimens but can occur.
- Fatigue, dehydration, mouth sores, and changes in taste can also occur.
Key safety notes
- Kidney function and electrolytes are closely watched; dehydration and NSAIDs/other nephrotoxic drugs should be avoided when possible.
- Ototoxicity risk means hearing tests may be done before and during therapy.
- Pregnancy: cisplatin can harm a fetus; effective contraception is important for people of reproductive potential.
- Interactions: avoid or be careful with other nephrotoxic drugs (e.g., certain antibiotics like aminoglycosides) and check with your oncologist about any medications you’re taking.
How this compares with other platinum drugs
- Cisplatin vs carboplatin: cisplatin is generally more nephrotoxic and more emetogenic (causes more nausea) but can be more active for certain cancers. Carboplatin tends to cause more bone marrow suppression but is easier on the kidneys. The choice depends on cancer type, patient kidney function, and other factors.
- Cisplatin vs oxaliplatin: oxaliplatin is less nephrotoxic and less emetogenic but is more associated with a unique neuropathy that can be triggered by cold (cold-induced dysesthesia).
If you’re preparing for treatment or supporting someone who is
- Ask your oncologist about the exact regimen, the expected cycle length, and how many cycles are planned.
- Ask about hydration protocol, antiemetics, and how electrolytes will be monitored and corrected.
- Inquire about potential side effects you should report urgently (dehydration signs, new hearing changes, persistent numbness, fever, severe vomiting, or inability to keep fluids down).
- Discuss fertility, pregnancy plans, and any need for contraception.
- Talk about what to expect for daily life during treatment and how to manage work, travel, or school.
If you can share the specific cancer type or regimen, I can give more tailored details about dosing ranges, monitoring, and what to expect during those cycles.